MoneyWorks4Me

The Total revenue for the quarter ended September 2021 of  Rs. 670.03 millions remain, more or less, the same.Handsome Net Profit growth of 99.93% reported above the corresponding previous quarter figure of Rs. 30.55 millions to Rs. 15.28 millions.Operating profit for the quarter ended September 2021 decreased to 73.17 millions as compared to 78.02 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202003 201903 % Var
Sales 670.03 642.76 4.24 3166.38 2870.02 10.33 1706.73 2230.79 -23.49
Other Income 9.11 3.93 131.81 29.57 44.89 -34.13 36.15 27.46 31.65
PBIDT 73.17 78.02 -6.22 358.21 238.80 50.00 98.74 230.54 -57.17
Interest 25.77 31.66 -18.60 143.83 183.64 -21.68 124.16 125.29 -0.90
PBDT 47.40 46.36 2.24 214.38 55.16 288.65 -25.42 105.25 -124.15
Depreciation 17.15 18.01 -4.78 83.39 103.21 -19.20 70.27 61.15 14.91
PBT 30.25 28.35 6.70 130.99 -48.05 -372.61 -95.69 44.10 -316.98
TAX -0.30 13.07 -102.30 31.78 15.57 104.11 -0.41 -23.49 -98.25
Deferred Tax 0.00 0.00 0.00 -2.48 0.00 0.00 0.00 0.00 0.00
PAT 30.55 15.28 99.93 99.21 -63.62 -255.94 -95.28 67.59 -240.97
Equity 148.22 141.72 4.59 148.22 141.72 4.59 141.72 141.72 0.00
PBIDTM(%) 10.92 12.14 -10.03 11.31 8.32 35.96 5.79 10.33 -44.02
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..